GLP-1 (Glucagon-like Peptide-1) is a hormone produced in the small intestine that helps regulate blood sugar levels by: Enhancing insulin secretion Suppressing glucagon release Slowing gastric emptying Reducing appetite What makes GLP-1 agonists especially promising is their broad distribution of receptors throughout the body, including in the brain, heart, kidneys, lungs, skin, and gastrointestinal tractindicating potential systemic effects that go well beyond glucose control
It does not typically interfere with the liver enzymes that process antibiotics, which is why there are few direct drug-to-drug interactions
Expecting it to do what GLP-1 agonists do is a massive category error
As millions of people seek out these treatments, telemedicine platforms are emerging as a convenient solution to access these medications without traditional in-person visits
Tirzepatide, Semaglutide, and Compound Medications While brand name versions of tirzepatide and semaglutide are FDA approved (Zepbound and WeGovy respectively), generic versions are not
This cost may vary depending on the pharmacy you select, your individualized dosage, and your eligibility for savings or assistance programs